Kewalramani Reshma
- SEC CIK
- 0001735944
In the past year, 1 open-market sale filing worth $19.7M and no purchases.
Current role at each company
- VRTX Vertex Pharmaceuticals IncCEO & Presidentas of Mar 3, 2026
- DNA Ginkgo Bioworks Holdings, Inc.Directoras of Jun 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $19.7M
- 1 filing
- Net
- −$19.7M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kewalramani Reshma as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRTX Vertex Pharmaceuticals Inc
CEO & President16 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Kewalramani ReshmaCEO & President | PPurchase | +10.0K | $195.65 | +$1.96M | +15.7%73.8K after | 2 lots |
| Jun 28, 2022 (view filing) | Jun 24 | 4 days | Kewalramani ReshmaCEO & President | SSale | −11.7K | $291.30 | −$3.41M | −9.5%111.2K after | From original |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Kewalramani ReshmaCEO & President | SSale | −11.7K | $305.06 | −$3.57M | −10.5%99.6K after | |
| Jan 27, 2023 (view filing) | Jan 25 | 2 days | Kewalramani ReshmaCEO & President | SSale | −10.0K | $315.05 | −$3.15M | −10.0%89.6K after | |
| May 1, 2023 (view filing) | Apr 27 | 4 days | Kewalramani ReshmaCEO & President | SSale | −3.32K | $339.08 | −$1.12M | −2.6%126.7K after | 3 lots10b5-1 |
| Jul 18, 2023 (view filing) | Jul 17 | 1 day | Kewalramani ReshmaCEO & President | SSale | −7.83K | $355.00 | −$2.78M | −6.2%118.9K after | 10b5-1 |
| Nov 15, 2023 (view filing) | Nov 13 | 2 days | Kewalramani ReshmaCEO & President | SSale | −5.10K | $377.00 | −$1.92M | −4.3%113.8K after | 10b5-1 |
| Dec 15, 2023 (view filing) | Dec 13 | 2 days | Kewalramani ReshmaCEO & President | SSale | −5.10K | $397.00 | −$2.02M | −4.5%108.7K after | 10b5-1 |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Kewalramani ReshmaCEO & President | SSale | −17.1K | $407.00 | −$6.97M | −13.6%108.7K after | 10b5-1 |
| May 22, 2024 (view filing) | May 20 | 2 days | Kewalramani ReshmaCEO & President | SSale | −15.2K | $447.00 | −$6.80M | −11.1%121.4K after | 10b5-1 |